Key Market Indicators
Slovak Antiinfective Medicine Sales are projected to rise to approximately $189 million by 2028, up from around $169 million in 2023. This represents an average annual growth rate of 1.8%. Since 2000, the Slovak market has seen a yearly increase of 4.1%. In 2023, Slovakia ranked 11th globally, with Norway surpassing it at $169 million. Spain, Croatia, and Australia occupied the second, third, and fourth spots, respectively, in this ranking. The import of antibiotics into Slovakia is expected to reach about $3.2 million by 2028, up from $3 million in 2023, marking an average annual growth rate of 0.8%. Since 1999, Slovak demand for antibiotics has grown by 3.2% year on year. On the export front, Slovakia's antibiotic shipments are forecasted to hit nearly $16.7 million by 2028, up from $15.1 million in 2023, translating to an average yearly growth rate of 1.5%. However, since 1999, Slovakia's antibiotic supply has seen a slight annual decrease of 0.9%.
